Liquidia Co. (NASDAQ:LQDA) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC lessened its stake in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) by 5.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,237,657 shares of the company's stock after selling 74,143 shares during the period. Geode Capital Management LLC owned about 1.61% of Liquidia worth $12,379,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of LQDA. Whitefort Capital Management LP raised its position in shares of Liquidia by 119.8% in the 3rd quarter. Whitefort Capital Management LP now owns 1,702,025 shares of the company's stock worth $17,020,000 after acquiring an additional 927,546 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Liquidia by 144.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 390,257 shares of the company's stock valued at $3,903,000 after buying an additional 230,820 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Liquidia by 18.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 207,961 shares of the company's stock worth $2,496,000 after acquiring an additional 32,076 shares in the last quarter. HighVista Strategies LLC grew its stake in Liquidia by 48.6% during the 3rd quarter. HighVista Strategies LLC now owns 180,947 shares of the company's stock valued at $1,809,000 after purchasing an additional 59,193 shares during the last quarter. Finally, Wellington Management Group LLP raised its stake in shares of Liquidia by 12.5% in the third quarter. Wellington Management Group LLP now owns 179,923 shares of the company's stock worth $1,799,000 after purchasing an additional 19,932 shares during the last quarter. Hedge funds and other institutional investors own 64.54% of the company's stock.

Analyst Ratings Changes

LQDA has been the subject of a number of recent research reports. Wells Fargo & Company assumed coverage on shares of Liquidia in a research report on Friday, December 20th. They set an "overweight" rating and a $20.00 price target for the company. HC Wainwright reissued a "buy" rating and set a $29.00 target price on shares of Liquidia in a report on Thursday, November 14th. Needham & Company LLC reissued a "buy" rating and issued a $19.00 price target on shares of Liquidia in a report on Thursday, November 14th. Scotiabank initiated coverage on Liquidia in a research note on Wednesday, October 16th. They issued a "sector outperform" rating and a $30.00 price target for the company. Finally, Lifesci Capital assumed coverage on Liquidia in a research report on Thursday, October 3rd. They set an "outperform" rating and a $30.00 price target on the stock. One research analyst has rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $25.38.

Liquidia Stock Performance

Shares of LQDA traded up $0.25 during trading hours on Wednesday, hitting $11.76. 423,458 shares of the stock were exchanged, compared to its average volume of 959,643. The stock's 50-day moving average price is $10.97 and its two-hundred day moving average price is $11.04. The company has a market cap of $995.33 million, a price-to-earnings ratio of -7.21 and a beta of 0.22. Liquidia Co. has a 12-month low of $8.26 and a 12-month high of $16.99.

Insider Activity at Liquidia

In other Liquidia news, insider Rajeev Saggar sold 2,260 shares of Liquidia stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $11.11, for a total transaction of $25,108.60. Following the transaction, the insider now directly owns 207,383 shares of the company's stock, valued at $2,304,025.13. The trade was a 1.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Roger Jeffs sold 8,053 shares of the stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $11.11, for a total transaction of $89,468.83. Following the completion of the sale, the chief executive officer now directly owns 812,193 shares of the company's stock, valued at approximately $9,023,464.23. This trade represents a 0.98 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,007 shares of company stock valued at $245,780. Corporate insiders own 30.10% of the company's stock.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).